Skip to main content

Advertisement

Table 1 Distribution of propensity score by treatment group in the BRAVO study

From: Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree

  Treatment group
Placebo Laquinimod 0.6 mg/day
Estimate Estimate
Quartile   
Maximum
Upper quartile 0.701 0.529
Median 0.586 0.407
Lower quartile 0.440 0.267
Minimum 0.109 0.007